Philippines Brain Cancer Therapeutics Market

Philippines Brain Cancer Therapeutics Market


$ 3999

Philippines Brain Cancer Therapeutics Market valued at $5 Mn in 2022, projected to reach $12 Mn by 2030 with a 11.1% CAGR. Anticipated increases in the occurrence of brain cancer, particularly glioblastoma multiforme, are expected to substantially boost the need for treatments targeting brain cancer, thereby impacting the market's overall landscape. Currently, prominent pharmaceutical entities in the market include Merck & Co, Amgen, Roche, Pfizer, Teva Pharmaceutical, Karyopharm Therapeutics, Novartis, AstraZeneca, Bristol Myers Squibb, and Eli Lilly.

ID: IN10PHPH439 CATEGORY: Pharmaceuticals GEOGRAPHY: Phillipines AUTHOR: Dr. Medha Sansanwal

Buy Now

Philippines Brain Cancer Therapeutics Market Executive Summary

Philippines Brain Cancer Therapeutics Market valued at $5 Mn in 2022, projected to reach $12 Mn by 2030 with a 11.1% CAGR.

The abnormal growth of brain cells serves as an indicator of brain cancer, wherein these cells display characteristics that can be either malignant (cancerous) or benign (non-cancerous). Although the precise cause of brain cancer remains unclear, recognized risk factors encompass exposure to ionizing radiation and a family history of brain tumors. Common symptoms associated with a brain tumor consist of headaches, gradual sensory decline, balance issues, speech impediments, and hearing difficulties. The presentation of these symptoms varies depending on factors like the tumor’s size, location, and growth rate. Treatment strategies for brain cancer are determined by the tumor’s type, location, and size, with frequently employed methods including radiosurgery, chemotherapy, radiotherapy, surgery, and the utilization of carmustine implants.

Cancer constitutes a significant health challenge in the Philippines, ranking among the leading causes of mortality in a population exceeding 110 Mn. Brain cancer, characterized by the abnormal growth of cells in the brain, presents as either malignant (cancerous) or benign (non-cancerous). Globally, brain tumors stand as the second most prevalent malignancy among children aged 0-14 years, with an incidence ranging from 1.12 to 5.14 cases per 100,000 individuals. In the Philippines, prevalent types of brain tumors include Astrocytoma (25.8%), Medulloblastoma (23.9%), Meningioma (45.1%), and Glioblastoma multiforme (7.5%). Addressing the specific challenges posed by these tumor types is essential for effective healthcare planning and resource allocation in the Philippines.

Avastin (bevacizumab), Temodar (temozolomide), Afinitor (everolimus), and other medications are approved for the treatment of brain tumors in the Philippines. Notably, City of Hope announced a significant milestone in October 2022 when the first patient was given a revolutionary drug that may be able to stop cancer. Furthermore, preliminary findings from a prospective pivotal trial evaluating Berubicin for the management of recurrent Glioblastoma Multiforme (GBM) were released by CNS Pharmaceuticals. The creation of next-generation cancer therapy medications is aided by the advancement of businesses such as Elpis Biopharmaceuticals and Regency Pharmaceuticals, demonstrating the changing landscape of brain tumor treatments.

Philippines brain cancer therapeutics market

Market Dynamics

Market Growth Drivers

Advancements in Treatment Options: The development of innovative medicines for brain-related disorders and technological advances in the healthcare industry are improving the effectiveness of treatments, which in turn is driving market expansion. The introduction of novel and efficacious treatments frequently results in a surge in the demand for these therapies. As the market expands, it attracts further investment, fostering a cycle of innovation, demand, and growth within the healthcare industry.

Increasing Incidence Rates: An increase in brain cancer incidence fuels the need for medications used in therapy. Effective pharmacological therapies may be required if brain cancer incidence rises due to factors like population expansion, aging demographics, and lifestyle changes.

Increasing Healthcare Awareness: Growing awareness about the importance of early detection, regular screenings, and access to advanced treatments for brain cancer can drive patient demand for effective pharmaceutical solutions. Increased public awareness often leads to a proactive approach to healthcare, influencing market growth.

Market Restraints

Regulatory Hurdles: The strict regulations and approval processes could create challenges for the creation and release of new medications for treating brain cancer, which may result in delays in their availability.

Limited Efficacy of Current Treatments: The efficacy of current treatments for brain cancer may be limited, underscoring the need for revolutionary innovations to significantly improve patient outcomes. This limitation has the potential to impact the market outlook for currently accessible drugs.

High Cost of Treatment: The substantial costs associated with advanced treatments such as targeted drugs and immunotherapies pose a financial challenge for both patients and the healthcare system. Financial hardship may be exacerbated by access to these expensive treatments being hampered by complex payment processes or inadequate insurance coverage. As a result, gaps in treatment availability due to socioeconomic reasons could appear, raising ethical questions about the equitable distribution of healthcare.

Healthcare Policies and Regulatory Landscape

In the Philippines, the regulatory landscape and healthcare policies governing treatment drugs are overseen by key entities, including the Food and Drug Administration (FDA), which ensures the safety and quality of pharmaceuticals through registration and post-market monitoring. The Department of Health (DOH) is crucial in establishing standards and rules for healthcare while working with the FDA. Purchasing and choosing necessary medications is influenced by the DOH's Philippine National Drug Formulary (PNDF). Furthermore, the Health Technology Assessment Council (HTAC) assesses the efficacy and cost-effectiveness of health technology, including medications, while the Philippine Health Insurance Corporation (PhilHealth) controls coverage and payment guidelines.

Competitive Landscape

Key Players

  • Merck & Co
  • Amgen
  • Roche
  • Pfizer
  • Teva Pharmaceutical
  • Karyopharm Therapeutics
  • Novartis
  • AstraZeneca
  • Bristol Myers Squibb
  • Eli Lilly

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Philippines Brain Cancer Therapeutics Market Segmentation

By Type

  • Gliomas
  • Meningiomas
  • Pituitary Adenomas
  • Vestibular Schwannomas
  • Neuroectodermal Tumours

By Treatment

  • Chemotherapy
  • Immunotherapy
  • Targeted Drug Therapy
  • Radiation Therapy
  • Others

By End-Users

  • Hospitals
  • Oncology Specialty Clinics
  • Oncology Treatment Centres
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 01 January 1970
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up